Related references
Note: Only part of the references are listed.Cocaine-induced neuroadaptations in glutamate transmission Potential therapeutic targets for craving and addiction
Heath D. Schmidt et al.
ADDICTION REVIEWS 2 (2010)
Behavioral and Functional Evidence of Metabotropic Glutamate Receptor 2/3 and Metabotropic Glutamate Receptor 5 Dysregulation in Cocaine-Escalated Rats: Factor in the Transition to Dependence
Yue Hao et al.
BIOLOGICAL PSYCHIATRY (2010)
2-Methyl-6(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat
Elizabeth L. van der Kam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat
Elizabeth L. van der Kam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
mGluR5 Has a Critical Role in Inhibitory Learning
Jian Xu et al.
JOURNAL OF NEUROSCIENCE (2009)
Dissociation of the Effects of MTEP [3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on Conditioned Reinstatement and Reinforcement: Comparison between Cocaine and a Conventional Reinforcer
R. Martin-Fardon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The glutamate homeostasis hypothesis of addiction
Peter W. Kalivas
NATURE REVIEWS NEUROSCIENCE (2009)
mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats
Justin T. Gass et al.
NEUROPSYCHOPHARMACOLOGY (2009)
BEHAVIORAL SENSITIZATION TO COCAINE IS ASSOCIATED WITH INCREASED GLUTAMATE RECEPTOR TRAFFICKING TO THE POSTSYNAPTIC DENSITY AFTER EXTENDED WITHDRAWAL PERIOD
M. B. Ghasemzadeh et al.
NEUROSCIENCE (2009)
Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats
Joyce Besheer et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Glutamatergic substrates of drug addiction and alcoholism
Justin T. Gass et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The endocannabinoid system in brain reward processes
M. Solinas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats
Andreas Gravius et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
MGluR5 Mediates the Interaction between Late-LTP, Network Activity, and Learning
Arthur Bikbaev et al.
PLOS ONE (2008)
Effect of 2-methyl-6-(phenyl ethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat
Elizabeth L. Van der Kam et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference
C. Maldonado et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration
Stephanie Caille et al.
JOURNAL OF NEUROSCIENCE (2007)
Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice
Jolanta Kotlinska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
Thomas M. Tzschentke
ADDICTION BIOLOGY (2007)
Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test
N. Sevostianova et al.
NEUROPHARMACOLOGY (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway
S Caillé et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?
RC Pierce et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats
JP Schroeder et al.
PSYCHOPHARMACOLOGY (2005)
The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats
NE Paterson et al.
PSYCHOPHARMACOLOGY (2005)
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats
PJ Kenny et al.
PSYCHOPHARMACOLOGY (2005)
Ionotropic and metabotropic glutamate receptor structure and pharmacology
JNC Kew et al.
PSYCHOPHARMACOLOGY (2005)
Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning
A Gravius et al.
BEHAVIOURAL PHARMACOLOGY (2005)
The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase Cε-dependent mechanism
MF Olive et al.
MOLECULAR PHARMACOLOGY (2005)
Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving
CA Heidbreder et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Time-dependent changes in extracellular glutamate in the rat dorsolateral striatum following a single cocaine injection
NL Mckee et al.
NEUROSCIENCE (2005)
The ups and downs of addiction: role of metabotropic glutamate receptors
PJ Kenny et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: Relevance for learning and memory formation
K Naie et al.
CEREBRAL CORTEX (2004)
Memory and addiction: Shared neural circuitry and molecular mechanisms
AE Kelley
NEURON (2004)
Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking
M Tessari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice
T Aoki et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice
AJ Mcgeehan et al.
PSYCHOPHARMACOLOGY (2004)
Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine
V Herzig et al.
NEUROPHARMACOLOGY (2004)
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine, (MTEP) in rodent models of anxiety
CS Busse et al.
NEUROPSYCHOPHARMACOLOGY (2004)
The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats
A Nazarian et al.
BRAIN RESEARCH BULLETIN (2004)
SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats
S Caillé et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders
W Spooren et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats
TJ De Vries et al.
PSYCHOPHARMACOLOGY (2003)
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice
NE Paterson et al.
PSYCHOPHARMACOLOGY (2003)
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse
AJ McGeehan et al.
SYNAPSE (2003)
3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity
NDP Cosford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist
P Popik et al.
NEUROPHARMACOLOGY (2002)
[3H]methoxymethyl-3-[(2-methylyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain:: In vitro and in vivo characterization
JJ Anderson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
D Robbe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Metabotropic glutamate receptors are involved in amygdaloid plasticity
M Fendt et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: Behavioral and neurochemical aspects
S Scheggi et al.
NEUROSCIENCE (2002)
Glutamatergic mechanisms in different disease states: overview and therapeutical implications - An introduction
TM Tzschentke
AMINO ACIDS (2002)
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
C Chiamulera et al.
NATURE NEUROSCIENCE (2001)
Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice
C Manzanedo et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
G Cossu et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism
DM O'Leary et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders
A Bisaga et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Context-specific enhancement of glutamate transmission by cocaine
K Bell et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies
LJMJ Vanderschuren et al.
PSYCHOPHARMACOLOGY (2000)
Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine)
R Ranaldi et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
